Express Scripts Holding Company (ESRX) belonging to the Medical sector has declined -0.05% and closed its last trading session at $63.09.
Currently, the stock has a 1 Year Price Target of $65.22.
The consensus recommendation, according to Zacks Investment research, is 2.46. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell.
The Stock had a 2.49 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 2.33 and 2.37 respectively.
Express Scripts Holding Company reported its EPS as $1.57 with the analysts projecting the EPS of the stock as $1.57.
Many analysts have provided their estimated foresights on Express Scripts Holding Company Earnings, with 20 analysts believing the company would generate an Average Estimate of $1.71.
Whereas they predicted High and Low Earnings Estimate as $1.74 and $1.7 respectively. While in the same Quarter Previous year, the Actual EPS was $1.57.
Analysts are also projecting an Average Revenue Estimate for Express Scripts Holding Company as $25.41 Million in the Current Quarter. This estimate is provided by 18 analysts.
The High Revenue estimate is predicted as 26.19 Million, while the Low Revenue Estimate prediction stands at 24.77 Million. The company’s last year sales total was 25.22 Million.
For the Current Quarter, the growth estimate for Express Scripts Holding Company is 8.9%, while for the Next Quarter the stock growth estimate is 9.2%.
In the past 5 years, the stock showed growth of 13.95% per annum. While for the next 5 years, the growth estimate is 11.93%.
Insider Trades for Express Scripts Holding Company show that the latest trade was made on 18 May 2017 where Anderson (Phyllis S), the Officer completed a transaction type “Sell” in which 1100 shares were traded at a price of $60.08.
Express Scripts Holding Company (ESRX) has the market capitalization of $37.88 Billion. The company rocked its 52-Week High of $80.02 and touched its 52-Week Low of $57.8.
The stock has Return on Assets (ROA) of 6.7 percent. Return on Equity (ROE) stands at 21.7% and Return on Investment (ROI) of 12.9 percent.
The stock is currently showing YTD performance of -8.29 Percent. The company has Beta Value of 0.91 and ATR value of 0.99. The Weekly and Monthly Volatility stands at 2.36% and 1.52%.